Global Alzheimer's Platform Foundation Develops Consortium

North America - United States

The Global Alzheimer's Platform (GAP) Foundation established a consortium of public and private stakeholders, including leading pharmaceutical companies, to develop the infrastructure to recruit participants for large scale Alzheimer's clinical trials. GAP's efforts also included establishing a global registry and a network of certified, high-performance clinical trial sites.

Faegre Baker Daniels served as counsel on the development of the consortium.

Faegre Baker Daniels 网站使用 Cookie 来提升您的浏览体验。